“IMPACT OF GLP-1 RECEPTOR AGONISTS ON LIVER ENZYMES AND FIBROSIS SCORES IN TYPE 2 DIABETIC AND NON-DIABETIC PATIENTS WITH FATTY LIVER DISEASE” (2026) Frontier in Medical and Health Research, 4(3), pp. 4646–4654. Available at: https://fmhr.net/index.php/fmhr/article/view/3859 (Accessed: 8 November 2026).